Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Assess the Impact of Pharmacological Intervention and Life Style Changes in the Reduction of Cardiovascular Disease in Patients With Diabetes Type 2 in Greece

NCT00648284 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00648284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00648284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Assess the Impact of Pharmacological Intervention and Life Style Changes in the Reduction of Cardiovascular Disease in Patients With Diabetes Type 2 in Greece
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
March 31, 2004
Completion date
Not reported
Enrollment
1,100
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cv risk, type 2 diabetes mellitus